Apollo Medical Holdings, Inc. Schedules 2022 First Quarter Financial Results Release and Conference Call
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will announce its first-quarter financial results for 2022 on May 5, 2022, after the market closes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will announce its first-quarter financial results for 2022 on May 5, 2022, after the market closes. A conference call to discuss the results is scheduled for 2 p.m. PT / 5 p.m. ET on the same day. The company operates an integrated healthcare delivery platform, focusing on value-based care. This announcement highlights the ongoing commitment of ApolloMed to providing high-quality healthcare solutions through its technology-powered services.
Positive
- Scheduled release of first-quarter financial results shows commitment to transparency.
- Focus on value-based care can enhance patient outcomes and cost efficiency.
Negative
- None.
Details
News Market Reaction – AMEH
The recorded move for AMEH in the trading session of this news was +1.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALHAMBRA, Calif., April 28, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the first quarter ended March 31, 2022, after the close of the stock market on Thursday, May 5, 2022. The Company will discuss those results in a conference call at 2 p.m. PT/5 p.m. ET that same day.
Participant Dial-in Numbers | |
U.S. & Canada (Toll-Free): | (877) 407-9753 |
International (Toll): | (201) 493-6739 |
To access the call, please dial in approximately five minutes before start time. An accompanying slide presentation will be available in PDF format on the "IR Calendar" page of the Company's website (https://www.apollomed.net/investors/news-events/ir-calendar) after issuance of the earnings release.
Webcast
The call will also be available via online webcast at: https://services.choruscall.com/mediaframe/webcast.html?webcastid=sp5fahlI.
Those who are unable to attend the live conference call may access the recording at the above webcast link, which will be made available shortly after the conclusion of the call.
About Apollo Medical Holdings, Inc.
ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.
Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models. For more information, please visit www.apollomed.net.
FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
investors@apollomed.net
Carolyne Sohn, The Equity Group
(415) 568-2255
csohn@equityny.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-schedules-2022-first-quarter-financial-results-release-and-conference-call-301535002.html
SOURCE Apollo Medical Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.